EU-BASED LABORATORY · NAVARRA, SPAIN PEPTIDES-ONLY POLICY · OPEN METHOD IA-SOP-001 DATA AS PUBLISHED · SOURCES DATED
Iberian AnalyticalIndependent peptide testing SECTION: LEARN · UPDATED SEPTEMBER 1, 2026

HomeLearnQuestions › Logistics

Can a capsule or oral peptide product be tested?

IA-Q-046 · logistics · answered September 1, 2026 · research use only

The short answer

Often yes, but it needs an extraction step first, because the peptide has to be separated from fillers, coatings and excipients before chromatography. That adds method development and cost compared with a lyophilised vial. Recovery from the matrix also becomes part of the uncertainty, and a report should say so rather than presenting the number bare.

In detail

The complication is the matrix, not the peptide. Excipients can interfere with detection, and incomplete extraction lowers the apparent content without anything being wrong with the product.

This is why oral and capsule formats are quoted individually rather than sitting on the standard tariff.

If you are assessing an oral product, be clear about which question you are asking: how much peptide is in the capsule, or how much survives a given condition.

Related questions

People also ask

All questions · Guides and comparisons

Iberian Analytical opens in Q1 2027 — €99 per test, 48–72 h target, and every result published in a public database, mandatory and free. Nothing is sold on this site today. Leave an email and we will write once, when the laboratory starts issuing certificates.

Have a question that is not here? Write to [email protected] — we answer in public, and every real question becomes a page.